尘螨变应原基因修饰树突状细胞治疗小鼠变应性鼻炎的实验研究
该研究制备尘螨变应原Der p1基因修饰的树突状细胞(Der p1-DC),在Balb/c小鼠变应性鼻炎模型中观察其疗效。24只小鼠分为4组,每组6只,分别给予Der p1-DC、未转染DC、地塞米松或生理盐水处理。结果显示Der p1-DC可降低血IgE、IgG1、组胺水平及鼻黏膜IL-4、IL-13表达,与地塞米松组无统计学差异,提示Der p1-DC可用于AR免疫治疗。
要点
- Der p1-DC降低AR小鼠血IgE、IgG1与组胺水平。
- Der p1-DC降低鼻黏膜IL-4与IL-13表达。
- Der p1-DC疗效与地塞米松组无统计学差异。
核心结论
- Der p1-DC可减轻AR小鼠炎症并降低IL-4与IL-13表达,提示可用于AR免疫治疗。
研究设计与样本
- 实验研究,24只健康雄性Balb/c小鼠按随机数表法分为4组,每组6只。
- 分组为imDC/AR组、糖皮质激素/AR组、Der p1-DC/AR组和imDC/正常组。
- 以Der p1建立AR小鼠模型,分别腹腔注射Der p1-DC、imDC、地塞米松或生理盐水。
主要发现
- Der p1-DC/AR组血IgE低于imDC/AR组[(0.560±0.110) OD 450 nm比(1.150±0.280) OD 450 nm,t=4.80,P<0.05]。
- Der p1-DC/AR组血IgG1低于imDC/AR组[(0.690±0.054) OD 450 nm比(0.920±0.125) OD 450 nm,t=4.14,P<0.05]。
- Der p1-DC/AR组血组胺低于imDC/AR组[(4 145±670) pg/ml比(7 685±669) pg/ml,t=9.16,P<0.05]。
- Der p1-DC/AR组鼻黏膜IL-4表达低于imDC/AR组(0.41±0.25比1.59±1.02,t=2.75,P<0.05)。
- Der p1-DC/AR组鼻黏膜IL-13表达低于imDC/AR组(0.26±0.01比1.10±0.09,t=22.72,P<0.05)。
关键数值与推荐
- Der p1-DC/AR组与地塞米松治疗组相比差异无统计学意义。
临床怎么用
- Der p1-DC在AR小鼠中显示减轻炎症和降低IL-4、IL-13表达的作用,提示其可能用于AR免疫治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the therapeutic effects of dendritic cells (DC) modified by the dust-mite-allergen(Der p1) gene on mouse model of allergic rhinitis (AR). Methods: DC modified by the Der p1 gene (Der p1-DC) were prepared.Using random number table, 24 Balb\c mice were divided into four groups: immature DC (imDC)/AR group, dexamethasone/AR group, Der p1-DC/AR group and control group, with 6 mice in each group.AR mouse model was built with Der p1 and the mouse model of AR was established.The AR mice were respectively given by abdominal injection of Der p1-DC, imDC and dexamethasone.Normal control mice were treated with physiologic saline.ELISA method was used for determining the content of IgE, IgG1and histamine in blood.The relative expression of mRNA of IL-4 and IL-13 on nasal mucosa with protein was analyzed by RT-PCR and Westen blot methods.All the data were statistically analyzed by SPSS 19.0 statistical software, and the variance analysis was used in multiple groups of average samples. Results: The contents of IgE, IgG1 and histamine in the mice of Der p1-DC/AR group were lower than those in imDC/AR group ((0.560±0.110) OD 450 nm vs (1.150±0.280) OD 450 nm, (0.690±0.054) OD 450 nm vs (0.920±0.125) OD 450 nm, (4 145±670) pg/ml vs (7 685±669) pg/ml, t value was 4.80, 4.14, 9.16, respectively, all P<0.05), and the expression of IL-4 and IL-13 on nasal mucosa in Der p1-DC/AR group was remarkedly lower than those in imDC/AR group (0.41±0.25 vs 1.59±1.02, 0.26±0.01 vs 1.10±0.09, t value was 2.75, 22.72, respectively, all P<0.05). There was no statistically significant difference between the mice treated with Der p1-DC and dexamethasone group. Conclusions: The results showed that Der p1-DC could reduce inflammation in AR mice and decrease the expression of IL-4 and IL-13. It suggested that Der p1-DC can be used in the immunotherapy of AR mouse. 目的: 探讨尘螨变应原(Der p1)基因修饰的树突状细胞(dendritic cells,DC)对变应性鼻炎(AR)小鼠的治疗效果。 方法: 制备Der p1基因修饰的DC(Der p1-DC)。将24只健康雄性Balb\c小鼠采用随机数表法分为4组:未转染基因DC(immature DC,imDC)/AR组;糖皮质激素/AR组;Der p1-DC/AR组;imDC/正常组,每组6只。以Der p1建立AR小鼠模型,分别给予腹腔注射Der p1-DC、imDC及地塞米松,同量生理盐水处理正常对照小鼠,使用酶联免疫吸附试验(ELISA)法测定血IgE、IgG1与组胺水平;反转录聚合酶链反应(RT-PCR)与Western blot法测定小鼠鼻黏膜白细胞介素(IL)-4、IL-13的mRNA与蛋白的表达。全部数据均经SPSS 19.0软件进行统计学分析,多组均数样本比较采用方差分析。 结果: Der p1-DC/AR组的血IgE、IgG1与组胺水平低于imDC/AR组[(0.560±0.110)OD 450 nm比(1.150±0.280)OD 450 nm,(0.690±0.054)OD 450 nm比(0.920±0.125)OD 450 nm,(4 145±670)pg/ml比(7 685±669)pg/ml,t值分别为4.80、4.14、9.16,P值均<0.05],鼻黏膜中IL-4与IL-13的表达明显低于imDC/AR组(0.41±0.25比1.59±1.02,0.26±0.01比1.10±0.09,t值分别为2.75、22.72,P值均<0.05),与地塞米松治疗组相比差异无统计学意义。 结论: Der p1-DC可以减轻AR小鼠的炎症,并降低IL-4与IL-13的表达,提示其可用于AR的免疫治疗。.
引用
- Che N, Han B, Liu SX, et al. [Experimental study on dendritic cells modified by dust mite allergen gene in the treatment of allergic rhinitis in mouse]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018. PMID: 30293259. doi:10.3760/cma.j.issn.1673-0860.2018.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。